Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Chromosomal Abnormalities
100%
Survival Prediction
100%
Small Lymphocytic Lymphoma
100%
Fine Needle Aspirate
100%
Multicolor Fluorescence in Situ Hybridization (mFISH)
100%
Fluorescence in Situ Hybridization
83%
17p13.1
83%
Risk of Death
66%
Fine-needle Aspiration
66%
Ki-67
33%
Aberrations
33%
Cytological Diagnosis
33%
Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma (CLL/SLL)
33%
Large B-cell Lymphoma
33%
Cell number
16%
Disease Progression
16%
Lymph Node
16%
Fluorescence in Situ Hybridization Analysis
16%
Immunostaining
16%
Chronic Lymphocytic Leukemia
16%
Accelerated Phase
16%
Chromosomal Aberrations
16%
Cytological Features
16%
Overall Survival Time
16%
High-grade Lymphoma
16%
Genetic Abnormalities
16%
Hybridization Probes
16%
Proliferation Index
16%
American Cancer Society
16%
Signal Pattern
16%
Normal Pattern
16%
Abnormal Signal
16%
Lysosome-associated Membrane Protein 1 (LAMP1)
16%
Multi-probe
16%
Proliferation Risk
16%
Medicine and Dentistry
Fluorescence in Situ Hybridization
100%
Chromosome Aberration
100%
Lymphocytic Lymphoma
100%
Fine-Needle Aspiration
44%
B-Cell Chronic Lymphocytic Leukemia
33%
Large-Cell Lymphoma
22%
Cytodiagnosis
22%
Malignant Neoplasm
11%
Immunohistochemistry
11%
Lymph Node
11%
Survival Time
11%
Overall Survival
11%
Protein P53
11%
Disease Exacerbation
11%
Non-Hodgkin Lymphoma
11%
Genetics
11%
Nursing and Health Professions
Chromosome Aberration
100%
Fluorescence in Situ Hybridization
100%
Lymphocytic Lymphoma
100%
Fine Needle Aspiration Biopsy
44%
Chronic Lymphatic Leukemia
33%
Large Cell Lymphoma
22%
Cytodiagnosis
22%
Survival Time
11%
Overall Survival
11%
Nonhodgkin Lymphoma
11%
Disease Exacerbation
11%
Protein P53
11%
Immunohistochemistry
11%
Staining
11%
Fluorescence in Situ Hybridization Kit
11%
Biochemistry, Genetics and Molecular Biology
Fluorescence in Situ Hybridization
100%
Chromosomal Abnormalities
100%
Ki-67
25%
Genetics
12%
P53
12%
Overall Survival
12%
Chromosomal Aberration
12%
Staining
12%
Immunostaining
12%
Survival Time
12%
LAMP1
12%
Hybridization Probe
12%